Unequivocal evidence for the clinical importance of DPP4 stems from the fact that its inhibitors are well acknowledged in pharmacotherapy of diabetes, helping to control the risk of atherosclerosis by reducing LDL-C levels, increasing HDL-C levels, and lowering blood pressure [36,37]. Here, DPP4 is linked to diabetes mellitus.